The source record

Source notes

Checked October 5, 2026. Provider pages document advertised terms. Study summaries identify the scope of our review.

1. FDA — unapproved uses of approved drugsRegulatory terminology
2. FDA — finding out whether a drug is approvedOfficial approval lookup guidance
3. FDA — compounding questions and answersCompounded-product context
4. FDA — concerns with unapproved GLP-1 productsMedication safety context
5. NIA — questions to ask during a checkupPatient communication guidance
6. NIA — talking with your doctor worksheetsPatient preparation resources
7. FDA — create and keep a medication listMedication-record guidance
8. FDA — prescription labeling questions and answersLabeling guidance
9. CoreAge Rx — semaglutide product offerProvider advertisement
10. CoreAge Rx — tirzepatide product offerProvider advertisement
11. CoreAge Rx — pricing and plan termsProvider policy
12. SuperHealthy Rx — GLP-1 offerProvider promotion
13. Likeness Rx — GLP-1 offer and termsProvider policy
14. Ro — Body programProvider membership offer
15. WeightWatchers — Med+ medication programProvider membership offer
16. LillyDirect — access to medicines and independent careManufacturer access pathway